About the Hematologist-Oncologists Session
Hematologist-Oncologists are highly trained physicians who diagnose and treat cancers of the blood as well as non-cancerous blood disorders. Their expertise spans conditions such as leukemia, lymphoma, myeloma, sickle cell anemia, thrombosis, and bleeding disorders. These specialists combine the fields of hematology and oncology, allowing them to manage complex cases where cancer directly affects the blood or immune system. Using blood tests, bone marrow biopsies, genetic analysis, and imaging, hematologist-oncologists create tailored treatment plans that may include chemotherapy, targeted drugs, immunotherapy, or stem cell transplants. Their work is essential in both acute and chronic disease management, often involving long-term follow-up and monitoring.
Hematologist-oncologists also play a vital role in patient education and emotional support, helping individuals and families understand their diagnosis and make informed decisions. They work within multidisciplinary teams, coordinating with nurses, radiologists, transplant specialists, and palliative care experts to ensure a comprehensive treatment approach. Their involvement often extends beyond treatment, guiding patients through remission, relapse prevention, or end-of-life care if needed. Many also contribute to clinical research, bringing access to cutting-edge therapies and advancing the understanding of rare blood cancers. With their dual specialization and compassionate care, hematologist-oncologists are essential to improving both survival outcomes and the overall well-being of patients facing blood-related diseases.
Topics Covered in Hematologist-Oncologists
Acute Leukemias
Lymphoma Subtypes
Multiple Myeloma
Sickle Cell Disease
Thrombosis & Bleeding
Bone Marrow Transplant
Related Scientific Sessions at CIOC 2027
Why Attend the Hematologist-Oncologists Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Hematologist-Oncologists work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Hematologist-Oncologists research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Hematologist-Oncologists track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Hematologist-Oncologists Conference 2027 — FAQs
What is the Hematologist-Oncologists track at CIOC 2027?
The Hematologist-Oncologists track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Hematologist-Oncologists. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Hematologist-Oncologists sessions?
Cancer researchers and clinicians, educators and students with an interest in Hematologist-Oncologists are all welcome — whether presenting or attending.
Can I present my research in the Hematologist-Oncologists track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Hematologist-Oncologists sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Hematologist-Oncologists track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
